Tolerability and Safety of Nano-Tocotrienols

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 360 participants.

Also called NCT07888426

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose other
Phase
Phase 2
Enrolled
  • 360 participants (planned count) (from the registry)
Sponsor
University of Malaya (from the registry)
Registry
  • NCT NCT07888426
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Malaysia (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07888426. Randomized; double masking; primary purpose other. Start 2026-10 (anticipated); primary completion 2029-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tolerability and Safety of Nano-Tocotrienols
Condition
Type 2 Diabetes Mellitus (DM)
Intervention (Drug)
Nano-tocotrienols
Intervention (Drug)
Placebo
Lead sponsor
University of Malaya (class: other)
Collaborator
Malaysia Palm Oil Board (class: other government)

Record details

Record id
cardio:ct-nct07888426
Content hash
bc099b5ebea92e4f48e4ebc955ffecd6a41584c751d89ed80388f0f9067b794e